المؤلفون: Carvalho, B, Lopes, JM, Silva, R, Peixoto, J, Leitão, D, Soares, P, Fernandes, AC, Linhares, P, Vaz, R, Lima, J

المساهمون: Instituto de Investigação e Inovação em Saúde

مصطلحات موضوعية: Adult, Aged, Bevacizumab / administration & dosage, Disease-Free Survival, Drug Resistance, Neoplasm / drug effects, Female, Gene Expression Regulation, Neoplastic / drug effects, Glioblastoma / blood supply, Glioblastoma / drug therapy, Glioblastoma / metabolism, Glioblastoma / mortality, Humans, Male, Middle Aged, Proto-Oncogene Proteins c-met / biosynthesis, Retrospective Studies, Survival Rate, Vascular Endothelial Growth Factor Receptor-2 / biosynthesis

وصف الملف: application/pdf

العلاقة: info:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FMED-ONC%2F31438%2F2017/PT; Scientific Reports, vol.11(1):6067; https://www.nature.com/articles/s41598-021-85385-1Test; https://hdl.handle.net/10216/152451Test

الإتاحة: https://doi.org/10.1038/s41598-021-85385-1Test
https://hdl.handle.net/10216/152451Test

المساهمون: Hae Min Kang, Jeong Hoon Choi, Hyoung Jun Koh, Sung Chul Lee, Koh, Hyoung Jun

مصطلحات موضوعية: Adult, Bevacizumab / administration & dosage, Bevacizumab / pharmacology, Bevacizumab / therapeutic use, Central Serous Chorioretinopathy / drug therapy, Female, Humans, Intravitreal Injections, Male, Middle Aged, Recurrence, Retrospective Studies, Time Factors, Treatment Outcome

وصف الملف: application/pdf

العلاقة: PLOS ONE; J02540; OAK-2021-01236; https://ir.ymlib.yonsei.ac.kr/handle/22282913/182561Test; T202006207; PLOS ONE, Vol.15(9) : e0238725, 2020-09

الإتاحة: https://doi.org/10.1371/journal.pone.0238725Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/182561Test

المساهمون: Junsik Park, Kyung Jin Eoh, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim, Jung Yun Lee, Kim, Sang Wun

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Bevacizumab / administration & dosage, Bevacizumab / therapeutic use, CA-125 Antigen, Carboplatin / administration & dosage, Carboplatin / therapeutic use, Carcinoma, Ovarian Epithelial / mortality, Ovarian Epithelial / pathology, Ovarian Epithelial / therapy, Cytoreduction Surgical Procedures / adverse effects, Cytoreduction Surgical Procedures / mortality, Female, Humans, Kaplan-Meier Estimate, Middle Aged, Neoadjuvant Therapy, Neoplasm Staging, Ovarian Neoplasms / mortality, Ovarian Neoplasms / pathology, Ovarian Neoplasms / therapy, Paclitaxel / administration & dosage, Paclitaxel / therapeutic use, Postoperative Complications, Retrospective Studies, Survival Analysis, Treatment Outcome

العلاقة: YONSEI MEDICAL JOURNAL; J02813; OAK-2020-07072; https://ir.ymlib.yonsei.ac.kr/handle/22282913/180453Test; T202004779; YONSEI MEDICAL JOURNAL, Vol.61(4) : 284-290, 2020-04; 67528

الإتاحة: https://doi.org/10.3349/ymj.2020.61.4.284Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/180453Test

المساهمون: Junwon Lee, Hee Jung Kwon, Min Kim, Christopher Seungkyu Lee, Sung Chul Lee, Kim, Min

مصطلحات موضوعية: Adult, Aged, Angiogenesis Inhibitors/administration & dosage, Bevacizumab/administration & dosage, Choroid Neoplasms/therapy, Choroidal Neovascularization/drug therapy, Female, Humans, Hyperthermia, Induced/methods, Intravitreal Injections, Male, Middle Aged, Retrospective Studies, Subretinal Fluid, Young Adult, Bevacizumab, Melanoma, Small pigmented choroidal lesion, Subfoveal fluid, Transpupillary thermotherapy

العلاقة: BMC OPHTHALMOLOGY; J00370; OAK-2019-01776; https://ir.ymlib.yonsei.ac.kr/handle/22282913/170060Test; T201901751; BMC OPHTHALMOLOGY, Vol.19(1) : 103, 2019; 61997

الإتاحة: https://doi.org/10.1186/s12886-019-1108-zTest
https://ir.ymlib.yonsei.ac.kr/handle/22282913/170060Test

المساهمون: College of Medicine, Dept. of Ophthalmology, Dong Hyun Lee, Hyun Goo Kang, Sung Chul Lee, Min Kim, Kang, Hyun Goo, Kim, Min, Lee, Sung Chul

مصطلحات موضوعية: Adult, Aged, Angiogenesis Inhibitors/administration & dosage, Bevacizumab/*administration & dosage, Choroid/*pathology, Choroidal Neovascularization/*diagnosis/etiology, Female, Fluorescein Angiography/*methods, Follow-Up Studies, Fovea Centralis/*pathology, Fundus Oculi, Humans, Intravitreal Injections, Male, Middle Aged, Degenerative/complications/diagnosis/*drug therapy Myopia, Predictive Value of Tests, Retrospective Studies, Optical Coherence/*methods Tomography, Vascular Endothelial Growth Factor A/antagonists & inhibitors, Visual Acuity, fluorescein angiography, myopic choroidal neovascularization, optical coherence tomography, pathologic myopia, treatment response

العلاقة: BRITISH JOURNAL OF OPHTHALMOLOGY; J00412; OAK-2018-00510; https://ir.ymlib.yonsei.ac.kr/handle/22282913/161958Test; https://bjo.bmj.com/content/102/2/238Test; T201800416; BRITISH JOURNAL OF OPHTHALMOLOGY, Vol.102(2) : 238-242, 2018

الإتاحة: https://doi.org/10.1136/bjophthalmol-2017-310244Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/161958Test
https://bjo.bmj.com/content/102/2/238Test

المساهمون: College of Medicine, Dept. of Ophthalmology, J H Lee, S C Lee, S Choi, H J Koh, S S Kim, C S Lee, Koh, Hyoung Jun, Kim, Sung Soo, Lee, Sung Chul, Lee, Seung Kyu, Lee, Ji Hwan

مصطلحات موضوعية: Adult, Aged, Angiogenesis Inhibitors/administration & dosage, Bevacizumab/administration & dosage, Choroidal Neovascularization/drug therapy, Female, Humans, Intravitreal Injections, Macula Lutea/pathology, Male, Middle Aged, Myopia, Degenerative/complications, Retrospective Studies, Visual Acuity

العلاقة: EYE; J00886; OAK-2017-07586; https://ir.ymlib.yonsei.ac.kr/handle/22282913/161655Test; T201705498; EYE, Vol.31(3) : 507-508, 2017

الإتاحة: https://doi.org/10.1038/eye.2016.249Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/161655Test

المساهمون: College of Medicine, Dept. of Ophthalmology, Lee, Ji Hwan, Lee, Sung Chul, Kim, Seo Hee, Koh, Hyoung Jun, Kim, Sung Soo, Byeon, Suk Ho, Lee, Christopher Seungkyu, Lee, Seung Kyu

مصطلحات موضوعية: Adult, Aged, Angiogenesis Inhibitors/administration & dosage, Atrophy/diagnosis, Atrophy/drug therapy, Atrophy/etiology, Bevacizumab/administration & dosage, Choroid/pathology, Choroidal Neovascularization/diagnosis, Choroidal Neovascularization/etiology Disease Progression, Female, Fluorescein Angiography/methods, Follow-Up Studies, Fundus Oculi, Humans, Intravitreal Injections, Male, Middle Aged, Myopia, Degenerative/complications, Degenerative/diagnosis, Ranibizumab/administration & dosage, Retinal Diseases/diagnosis, Retinal Diseases/drug therapy, Retinal Diseases/etiology, Retrospective Studies, Time Factors, Tomography, Optical Coherence/methods, Treatment Outcome

العلاقة: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES; J02621; OAK-2017-06106; https://ir.ymlib.yonsei.ac.kr/handle/22282913/161187Test; https://oce.ovid.com/article/00006982-201708000-00011/HTMLTest; T201704260; RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, Vol.37(8) : 1516-1522, 2017

الإتاحة: https://doi.org/10.1097/IAE.0000000000001384Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/161187Test
https://oce.ovid.com/article/00006982-201708000-00011/HTMLTest

المساهمون: College of Medicine, Dept. of Ophthalmology, Kyou Ho Lee, Seo Hee Kim, Ji Min Lee, Eui Chun Kang, Hyoung Jun Koh, Kang, Eui Chun, Koh, Hyoung Jun, Kim, Seo Hee, Lee, Kyou Ho

مصطلحات موضوعية: Aged, Angiogenesis Inducing Agents/administration & dosage, Bevacizumab/administration & dosage, Choroid/blood supply, Choroid/pathology, Choroid Diseases/diagnosis, Choroid Diseases/drug therapy, Female, Fluorescein Angiography, Follow-Up Studies, Fundus Oculi, Humans, Intravitreal Injections, Macula Lutea/pathology, Male, Middle Aged, Optic Disk/pathology, Ranibizumab/administration & dosage, Retrospective Studies, Tomography, Optical Coherence, Treatment Outcome, Vascular Endothelial Growth Factor A/antagonists & inhibitors, Visual Acuity, Anti-vascular endothelial growth factor, Choroid, Macular degeneration, Polypoidal choroidal vasculopathy

العلاقة: Korean Journal of Ophthalmology; J02931; OAK-2017-05309; https://ir.ymlib.yonsei.ac.kr/handle/22282913/160940Test; T201703697; Korean Journal of Ophthalmology, Vol.31(5) : 431-438, 2017

الإتاحة: https://doi.org/10.3341/kjo.2016.0101Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/160940Test

المساهمون: College of Medicine, Dept. of Ophthalmology, Kyou Ho Lee, Eui Chun Kang, Hyoung Jun Koh, Kang, Eui Chun, Koh, Hyoung Jun, Lee, Kyou Ho

مصطلحات موضوعية: Aged, Angiogenesis Inhibitors/administration & dosage, Bevacizumab/administration & dosage, Dexamethasone/administration & dosage, Drug Implants, Drug Resistance, Female, Follow-Up Studies, Glucocorticoids/administration & dosage, Humans, Intravitreal Injections, Macular Edema/diagnosis, Macular Edema/drug therapy, Macular Edema/etiology, Male, Retinal Vein Occlusion/complications, Retinal Vein Occlusion/diagnosis, Retrospective Studies, Tomography, Optical Coherence, Treatment Outcome, Visual Acuity, PURPOSE: To evaluate the prognostic factors and outcomes of dexamethasone intravitreal implant (DEX implant) for intravitreal bevacizumab refractory macular edema secondary to branch retinal vein occlusion (BRVO). METHODS: This was a retrospective, interventional case series. Medical records were reviewed, and a total of 38 eyes that were treated with DEX implant for macular edema secondary to BRVO that did not respond to at least two consecutive intravitreal bevacizumab injections (IBIs) were included. Best-corrected visual acuity (BCVA), central subfield macular thickness, and central subfoveal choroidal thickness were evaluated at baseline, 2 months, and 6 months after DEX implantation. RESULTS: Patients had undergone an average of 6.32 짹 4.66 prior IBI treatments. The average BCVA improved from 0.53 짹 0.26 to 0.41 짹 0.25 and 0.44 짹 0.23 logarithm of the minimal angle of resolution (logMAR) at 2 and 6 months, respectively (p < 0.001). The average central subfield macular thickness was 504.00 짹 121.54 쨉m at baseline and changed to 293.21 짹 74.17 쨉m and 427.28 짹 119.57 쨉m at 2 and 6 months

العلاقة: Korean Journal of Ophthalmology; J02931; OAK-2017-04364; https://ir.ymlib.yonsei.ac.kr/handle/22282913/160667Test; T201703032; Korean Journal of Ophthalmology, Vol.31(2) : 108-114, 2017

الإتاحة: https://doi.org/10.3341/kjo.2017.31.2.108Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/160667Test

المؤلفون: Kowalczuk, L., Matet, A., Dirani, A., Daruich, A., Ambresin, A., Mantel, I., Spaide, R.F., Turck, N., Behar-Cohen, F.

المصدر: Retina, vol. 37, no. 12, pp. 2226-2237

مصطلحات موضوعية: Aged, Angiogenesis Inhibitors/administration & dosage, Bevacizumab/administration & dosage, Dose-Response Relationship, Drug, Drug Resistance, Female, Follow-Up Studies, Humans, Intravitreal Injections, Male, Middle Aged, Receptors, Vascular Endothelial Growth Factor/administration & dosage, Vascular Endothelial Growth Factor/antagonists & inhibitors, Recombinant Fusion Proteins/administration & dosage, Retina/pathology, Retinal Telangiectasis/diagnosis, Retinal Telangiectasis/drug therapy, Retrospective Studies, Time Factors, Tomography, Optical Coherence/methods, Treatment Outcome, Visual Acuity

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28002269; info:eu-repo/semantics/altIdentifier/eissn/1539-2864; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_7E8EB5F88A932; https://serval.unil.ch/notice/serval:BIB_7E8EB5F88A93Test; urn:issn:0275-004X; https://serval.unil.ch/resource/serval:BIB_7E8EB5F88A93.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_7E8EB5F88A932Test

الإتاحة: https://doi.org/10.1097/IAE.0000000000001424Test
https://serval.unil.ch/notice/serval:BIB_7E8EB5F88A93Test
https://serval.unil.ch/resource/serval:BIB_7E8EB5F88A93.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_7E8EB5F88A932Test